Somatic DMD gene mutations and/or defective dystrophin expression has been found in various types of cancer, including non-myogenic tumors in humans (Korner et al, 2007; Wang et al, 2014; Luce et al, 2017; Gallia et al, 2018; Juratli et al, 2018; Mauduit et al, 2019). This evidence concerns the gene DMD and cancer.